Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Acta Neurochirurgica
Literature
1.
Aldave G, Tejada S, Pay E, Marigil M, Bejarano B, Idoate MA, Diez-Valle R (2013) Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic acid-guided surgery. Neurosurg 72:915–920, discussion 920–1CrossRef
2.
Diez Valle R, Tejada Solis S, Idoate Gastearena MA, Garcia de Eulate R, Dominguez Echavarri P, Aristu Mendiroz J (2011) Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience. J Neurooncol 102:105–113PubMedCrossRef
3.
Hatiboglu MA, Weinberg JS, Suki D, Rao G, Prabhu SS, Shah K, Jackson E, Sawaya R (2009) Impact of intraoperative high-field magnetic resonance imaging guidance on glioma surgery: a prospective volumetric analysis. Neurosurg 64:1073–1081, discussion 1081CrossRef
4.
Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115:3–8PubMedCrossRef
5.
Schucht P, Beck J, Abu-Isa J, Andereggen L, Murek M, Seidel K, Stieglitz L, Raabe A (2012) Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping. Neurosurg 71:927–936CrossRef
6.
Stummer W, Meinel T, Ewelt C, Martus P, Jakobs O, Felsberg J, Reifenberger G (2012) Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery. J Neurooncol 108:89–97PubMedCentralPubMedCrossRef
7.
Vogelbaum MA, Jost S, Aghi MK, Heimberger AB, Sampson JH, Wen PY, Macdonald DR, Van den Bent MJ, Chang SM (2012) Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group. Neurosurg 70:234–243, discussion 243–4CrossRef
8.
Pastor J, Vega-Zelaya L, Pulido P, Garnés-Camarena O, Abreu A, Sola RG (2013) Role of intraoperative neurophysiological monitoring during fluorescence-guided resection surgery. Acta Neurochir (Wien) 155:2201-2213
Metadata
Title
Resection in glioblastoma: maximal or safe
Authors
Ricardo Diez Valle
Sonia Tejada
Publication date
01-02-2014
Publisher
Springer Vienna
Published in
Acta Neurochirurgica / Issue 2/2014
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-013-1967-7

Other articles of this Issue 2/2014

Acta Neurochirurgica 2/2014 Go to the issue

Letter to the editor - Brain Tumors

Rheumatoid arthritis mimicking an intracranial malignancy

Review Article - Brain Tumors

Approaches to temporal lobe lesions: a proposal for classification

Clinical Article - Brain Tumors

Extent of resection and survival in supratentorial infiltrative low-grade gliomas: analysis of and adjustment for treatment bias

Clinical Article - Brain Tumors

Surgical management of diffuse low-grade gliomas associated with other intracranial diseases

Case Report - Neurosurgical Techniques

Venous air embolism (VAE) associated with stereotactic biopsies

Clinical Article - Brain Tumors

Long-term quality of life and tumour control following gamma knife radiosurgery for vestibular schwannoma